DUBLIN, Nov. 16, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/2jdl37/global_drug) has announced the addition of the "Global Drug Delivery Partnering 2010-2015: Deal trends, players and financials" report to their offering.
The Global Drug Delivery Partnering 2010-2015 report provides comprehensive understanding and unprecedented access to the drug delivery partnering deals and agreements entered into by the worlds leading healthcare companies.
The report provides a detailed understanding and analysis of how and why companies enter drug delivery partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors drug delivery technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.
Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases do not.
Drug Delivery
- Bioavailability
- Implanatable
- Oral delivery
- Rapid release
- Delayed release
- Parenteral
- Infusion
- Injectable
- Pro-drug
- Targeted
- Topical
- Transdermal
- Buccal
- Inhaled
- Nasal
- Ocular
- Rectal
- Sublingual
- Urogenital
Global Drug Delivery Partnering 2010-2015 includes:
- Trends in drug delivery dealmaking in the biopharma industry since 2010
- Analysis of drug delivery deal structure and contract documents
- Access to headline, upfront, milestone and royalty data
- Case studies of real-life drug delivery deals
- Access to over 2,000 drug delivery deals announced
- The leading drug delivery deals by value since 2010
- Most active drug delivery dealmakers since 2010
- The leading drug delivery partnering resources
In Global Drug Delivery Partnering 2010-2015, the available contracts are listed by:
- Company A-Z
- Headline value
- Stage of development at signing
- Deal component type
- Specific therapy target
Key Topics Covered:
Executive Summary
Chapter 1 - Introduction
Chapter 2 - Trends in drug delivery dealmaking
Chapter 3 - Leading drug delivery deals
Chapter 4 - Big pharma drug delivery deals
Chapter 5 - Big biotech drug delivery deals
Chapter 6 - Drug delivery partnering contracts directory
Chapter 7 - Drug delivery dealmaking by technology type
Companies Mentioned
- 3M
- 3M Drug Delivery Systems
- AAIPharma Services
- Abbott
- Accredo Health Group
- Acelrx Pharmaceuticals
- Acorda Therapeutics
- Actavis
- Actelion
- Actient Pharmaceuticals
- Adeona Pharmaceuticals
- Adolor
- Alchemia
- Aldexa Therapeutics
- Alexza Pharmaceuticals
- Alfacell
- Alimera Sciences
- Alkermes
- Allergan
- Allos Therapeutics
- Amag Pharmaceuticals
- AMAG Pharmaceuticals
- Amarillo Biosciences
- Amarin
- Amicus Therapeutics
- Ampio Pharmaceuticals
- Amylin Pharmaceuticals
- Anesiva
- Angiotech Pharmaceuticals
- AP Pharma
- Apricus Biosciences
- Aradigm
- Aristos Pharmaceuticals
- Arius Pharmaceuticals
- Array Biopharma
- Astellas
- AstraZeneca
- Audeo Oncology
- Auxilium Pharmaceuticals
- AVI Pharma
- Azur Pharma
- Bausch & Lomb
- Baxter International
- Bayer
- BIND Biosciences
- BIND Therapeutics
- BioArray Solutions
- Biocon
- BioCryst Pharmaceuticals
- BioDelivery Sciences
- Biogen Idec
- BiolineRX
- Bio-Path
- Biopharmex
- BioSante Pharmaceuticals
- Biovail
- BioZone Laboratories
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Calando Pharmaceuticals
- Caleco Pharma
- Caleco Pharma Europe
- Cambridge Laboratories
- Cangene
- Caraco Pharmaceuticals
- Cardinal Health
- Cardium Therapeutics
- Cary Pharmaceuticals
- Catalent Pharma Solutions
- Celgene
- Celladon
- Cerulean Pharma
- Clarus Therapeutics
- Columbia Laboratories
- CombinatoRx
- Control Delivery Systems
- Corium International
- Cornerstone Therapeutics
- Cortex Pharmaceuticals
- Crawford Healthcare
- Critical Therapeutics
- CSL
- Cubist
- Cumberland Pharmaceuticals
- Cutanea Life Sciences
- Cyclacel Pharmaceuticals
- CyDex
- Cypress Bioscience
- Daiichi Sankyo
- Dainippon Sumitomo
- Dalian Wande Electronics
- Debiopharm
- Dechra Pharmaceuticals
- Defense Threat Reduction Agency
- Dehaier Medical Systems
- Dendreon
- Department of Defense
- Department of Homeland Security
- DepoMed
- Dey Pharma
- Dipexium Pharmaceuticals
- DNA Biomedical Solutions
- DoctorDirectory
- Dov Pharmaceutical
- DPT Laboratories
- Drugs for Neglected Diseases Initiative
- Duoject Medical Systems
- Duramed
- Durect
- Dyax
- Echo Therapeutics
- ECR Pharmaceuticals
- Egalet
- Eisai
- EKR Therapeutics
- Elan
- Eli Lilly
- Elite Pharmaceuticals
- Emergent BioSolutions
- Emisphere
- Endo Pharmaceuticals
- Entera Bio
- Epic Pharmaceuticals
- Evonik Industries
- Facet Biotechnology
- FasTrack Pharmaceuticals
- Ferndale Pharmaceuticals
- Finorga
- Fleet Laboratories
- Forest Laboratories
- Fovea Pharmaceuticals
- Fresenius
- Galapagos
- Galderma
- Genentech
- Generex Biotechnology
- GenVec
- Ghent University
- Gilead Sciences
- GlaxoSmithKline
- Global Health Ventures
- Globe Laboratories
- GlobeImmune
- Graceway Pharmaceuticals
- Green Vision
- Grifols
- Hadasit Medical Research Services and Development
- Halo Pharmaceutical
- Halozyme Therapeutics
- Hangzhou Zhencheng Pharmaceuticals
- Helix BioMedix
- Horizon Pharma AG
- Horizon Pharma Inc
- Hospira
- Hunan Jiuwang Pharmaceuticals
- Idenix Pharmaceuticals
- Ikaria
- ImaRX
- Imprimis Pharmaceuticals
- Inalco Biochemicals
- Inalco Group
- Incyte
- Inovio Pharmaceuticals
- Insmed Inc
- Inspire Pharmaceuticals
- Intas Biopharmaceuticals
- IntelGenx
- Intendis
- InterMune
- Intrexon
- Ipsen
- Ironwood Pharmaceuticals
- Isis Pharmaceuticals
- Jagotec
- Janssen Pharmaceuticals
- Javelin Pharmaceuticals
- Jazz Pharmaceuticals
- Jiangsu Yabang Pharmaceuticals
- Johnson & Johnson
- JPI Commercial
- King Pharmaceuticals
- Krele Pharmaceuticals
- Kunwha Pharmaceuticals
- KV Pharmaceutical
- Kyowa Hakko Kirin
- Kythera Biopharmaceuticals
- LFB Group
- Ligand Pharmaceuticals
- Lipocine
- Lonza
- Los Angeles Biomedical Research Institute
- Lundbeck
- Lupin Pharmaceuticals
- Mallinckrodt Pharmaceuticals
- MAP Pharmaceuticals
- Marina Biotech
- McCoy Enterprises
- McKesson
- McNeil PPC
- MD Anderson Cancer Center
- MDRNA
- Meda
- Medgenics
- MediciNova
- Medicis Pharma
- Medpace
- Meiji Seika
- Melinta Therapeutics
- Memorial Sloan Kettering Cancer Center
- Menarini
- Merck & Co
- Merck KGaA
- Merial
- Merrimack Pharmaceuticals
- Mglas
- Microbix Biosystems
- MiddleBrook Pharmaceutical
- Mikah Pharma
- Millennium
- Mirna Therapeutics
- Mist Acquisition
- Monsanto
- Morphosys
- Mundipharma
- Mylan
- Mylan Laboratories
- Nastech Pharmaceutical
- Nektar Therapeutics
- NeurogesX
- Neuromed
- Neuronex
- Nitec Pharma
- Norgine
- NovaDel Pharma
- Novartis
- Novasep
- Novo Nordisk
- Novozymes Biopharma
- NPS Pharmaceuticals
- NuGlow Cosmaceuticals
- NuPathe
- Nycomed
- Oculus Innovative Sciences
- Omthera Pharmaceuticals
- OncoSec Medical
- Onyx Pharmaceuticals
- Oradisc
- Oramed Pharmaceuticals
- Orexigen Therapeutics
- Ortho-McNeil-Janssen Pharmaceuticals
- Oso Bio Pharmaceuticals
- Otsuka
- Pacira Pharmaceuticals
- Par Pharmaceutical
- Patheon
- PDL BioPharma
- Pfizer
- PharmaEngine
- Pipex Pharmaceuticals
- Planned Systems International (PSI)
- Pozen
- Prasco Laboratories
- Prestige Brands
- Procter & Gamble
- Professional Compounding Centers of America
- ProNAi Therapeutics
- PSivida
- Purdue
- Purdue Pharma
- QLT
- Questcor Pharmaceuticals
- Quintiles
- Radius Health
- Ranbaxy Laboratories
- Receptos
- Rechon Life Sciences
- RedHill Biopharma
- Regeneron Pharmaceuticals
- Revance Therapeutics
- Rigel Pharmaceuticals
- Roche
- RRD International
- S2 Therapeutics
- Sagent Pharmaceuticals
- Salix Pharmaceuticals
- Sangamo BioSciences
- Sankyo Pharmaceutical
- Sanofi
- Sanofi-Aventis
- Santarus
- SciClone Pharmaceuticals
- Scolr Pharma
- Scynexis
- Seattle Genetics
- Serenity Pharmaceuticals
- Servier
- Shaanxi Jiali Pharmaceuticals
- Shandong Yaoshan Pharmaceuticals
- Shionogi
- Shire
- Sigma-Aldrich
- SK Biopharmaceuticals
- SkyePharma
- SLA Pharma
- Smiths Medical
- Solvay
- Southern Research Institute
- Sovereign Pharmaceuticals
- Spectrum Pharmaceuticals
- Spring Creek Capital
- SRI International
- Stada
- Strakan
- Strativa Pharmaceuticals
- Sun Pharmaceutical
- Supernus Pharmaceuticals
- SurModics
- Swedish Orphan Biovitrum
- Symphony Allegro
- Takeda
- Tandem Diabetes Care
- Tarsa Therapeutics
- Teikoku Pharma USA
- Teikoku Seiyaku
- Teva
- The Medical Research, Infrastructure, and Health Services Fund of the Tel Aviv Medical Center
- The Medicines Company
- The Regents of the University of California
- Therabel
- Transcept Pharmaceuticals
- Transdel Pharmaceuticals
- Tranzyme Pharma
- TTY Biopharm
- UCB
- Ultragenyx Pharmaceuticals
- Uluru
- Unigene Laboratories
- United Therapeutics
- Valeant
- Vanda Pharmaceuticals
- Ventrus Biosciences
- VeroScience
- Vertex Pharmaceuticals
- VetCure
- Viropharma
- WA 32609
- Warner Chilcott
- Washington Research Foundation
- Watson Laboratories
- Watson Pharmaceuticals
- Xi'an Zaolutang Kushidai Pharmaceuticals
- XTL Biopharmaceuticals
- Yamasa
- Zogenix
- ZymoGenetics
For more information visit http://www.researchandmarkets.com/research/2jdl37/global_drug
Media Contact:
Laura Wood, +353-1-481-1716, press@researchandmarkets.net
